Abolition of specific immune response defect by immunization with dendritic cells

Area of Science:

• Immunology
• Genetics

Background:

• Cytotoxic T (Tc)-cell responses are governed by immune response (Ir) genes within the major histocompatibility complex (H-2).
• The H-2 I-Ab mutant mouse strain bm12 exhibits non-responsiveness to H-Y antigen, failing to reject H-Y disparate skin grafts due to specific mutations in the H-2 class II molecule.

Purpose of the Study:

• To investigate if dendritic cells (DC) can induce H-Y-specific cytotoxic T (Tc)-cell responses in H-Y nonresponder bm12 mice.
• To explore the role of T-helper (Th) cells and antigen-presenting cells (APC) in overcoming specific immune response defects.

Main Methods:

• Priming female bm12 mice in vivo and restimulating in vitro with male bm12 dendritic cells (DC).
• Assessing H-Y-specific Tc-cell generation and H-Y disparate skin graft rejection.
• Analyzing responder cell populations for the presence of L3T4+ (Th) and Lyt 2+ (Tc) T lymphocytes.

Main Results:

• Priming and restimulation with male bm12 DC induced strong H-Y-specific Tc-cell responses in female bm12 mice.
• These mice subsequently rejected H-Y disparate skin grafts, indicating a conversion from non-responder to responder status.
• Successful H-Y-specific Tc-cell generation required responder cell populations containing both L3T4+ (Th) and Lyt 2+ (Tc) T lymphocytes.

Conclusions:

• Dendritic cells (DC) act as potent antigen-presenting cells (APC) that activate T-helper (Th) cells, crucial for converting H-Y nonresponder bm12 mice into H-Y responders.
• This DC-mediated priming strategy can elicit T-cell repertoire responses not typically observed with standard immunization methods.
• The findings suggest a potential therapeutic approach for overcoming other specific immune response defects using DC-based immunization.